CClinicalTrials.gg
CompletedNCT03836391NudgeUpdated Nov 13, 2019

Precision Public Health: Enhancing Connections to Develop Just-in-Time Adaptive Intervention Strategies

An interventional study of Nudge in Overweight and Obesity, Overweight and Obesity, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-11-13.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The purpose of this pilot study is to examine the effects of different types of just-in-time intervention messages on daily meeting dietary, activity, and weighing goals in a sample of young adults participating in a mobile-based weight loss program.

Read the detailed description

Public health interventions typically rely on a set schedule of intervention delivery. Advances in technology and computer tailoring allow us to go from a "one size fits all" approach to one that uses digital health data to deliver "just-in-time adaptive interventions," or JITAIs, that can vary the timing, dose, and content of intervention messages to individuals. This pilot study is a micro-randomized trial that evaluates the effects of various intervention message options delivered in JIT moments on meeting dietary, activity, and weighing goals among young adults in a mobile-based weight loss program.

The Nudge study is a 12-week mobile health weight loss program delivered via a native smartphone application. Individuals are asked to track their red foods (high-calorie, high-fat foods) in the app daily and meet their personalized red foods goal, wear a Fitbit daily and meet their daily active minutes goal, and weigh daily on their WiFi-enabled scale. Up to 4 times each day, participants are randomized to receive or not receive intervention messages in order to examine the effects of these intervention message types on meeting daily weighing goals, red food goals, and activity goals. This is a within-subjects design in which each participant serves as their own control, and data is analyzed at the person-day level.

02

Conditions studied

  • Overweight and Obesity
  • Overweight
  • Obesity

Keywords

  • Mobile health
  • Physical activity
  • Nutrition
  • Self-monitoring
  • Smartphone app
  • Digital health tools
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 53 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age 18-35
  • BMI of 25-40 kg/m²
  • Not adhering to the US physical activity guidelines of at least 150 moderate-to-vigorous intensity activity minutes/week
  • English-speaking and writing
  • No pre-existing medical condition(s) that preclude adherence to an unsupervised exercise program, diabetes treated with insulin, history of heart attack or stroke, current treatment for cancer, or inability to walk for exercise
  • Has an iPhone with iOS 11 (or willing to download it) with internet access and text messaging plan
  • Has home wireless access compatible with Fitbit Aria 2 scale (802.11b/g/n)

Exclusion criteria

Exclusion Criteria:

  • Current participation in another physical activity or weight control program
  • Currently pregnant, pregnant in last 6 months, or planning pregnancy in next 3 months
  • Report a heart condition, chest pain during periods of activity or rest, loss of consciousness, joint or bone problems, or prescription medicine usage for blood pressure or heart condition on the Physical Activity Readiness Questionnaire (PAR-Q)
  • Health or psychological diagnoses that preclude participation in a prescribed dietary and exercise program, including diagnosis of schizophrenia or bipolar disorder, hospitalization for a psychiatric diagnosis in the past year, diagnosis of alcohol or substance abuse
  • Occupation requires primarily night shift work
  • Owns and uses a physical activity tracker
  • Moving out of area in next 4 months
  • Out of town for a week or more during study period
  • Not willing to attend two study visits
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    Nudge Intervention

    Each of 7 intervention message options has specific decision rules (including weighed/not weighed and progress toward daily dietary and activity goals) that make a participant eligible to receive a specific intervention type at a specific time (decision points). At each decision point (early morning, morning, midday, and evening), the system evaluates which intervention options a participant is eligible to receive, and randomly chooses one intervention option from that list. Then the participant is randomly assigned to either receive or not receive that intervention message (with a 50-50 probability).

    Behavioral: Nudge

Interventions

  • BehavioralNudge

    Nudge is a smartphone-app-based micro-randomized trial that tests the effect of 7 intervention message types based on behavior change techniques on daily goal attainment. Participants have three daily goals: weigh daily, red foods goal, and active minutes goal.

06

What researchers measure

Primary outcomes

  1. Percent of person-days with same-day weighing

    Percent who weighed after the message randomization time until the end of the day (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

  2. Percent of person-days with next-day weighing

    Percent who weighed the day after the message randomization (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

  3. Percent of person-days met active minutes goal on same day

    Percent who met active minutes goal after the message randomization time until the end of the day (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

  4. Percent of person-days met active minutes goal on next day

    Percent who met active minutes goal the day after the message randomization (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

  5. Percent of person-days met red foods goal on same day

    Percent who met red foods goal after the message randomization time until the end of the day (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

  6. Percent of person-days met red foods goal on next day

    Percent who met red foods goal the day after the message randomization (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

Secondary outcomes

  1. Number of active minutes

    Total number of active minutes on the day of message randomization (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

  2. Proximal effect of message on total red foods today

    Total number of red foods on the day of message randomization (at the participant-day level) across the 12-week study

    Time frame: from Baseline to Week 12

  3. Mean weight change

    Mean weight change across participants

    Time frame: from Baseline to Week 12

07

Study locations

1 site
  • Department of Health Behavior, University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina 27599, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03836391
Lead sponsor
University of North Carolina, Chapel Hill
Responsible party
Sponsor
First posted
Feb 11, 2019
Start date
Feb 12, 2019
Primary completion
Sep 16, 2019
Completion
Sep 16, 2019
Last update
Nov 13, 2019

Study contacts

Deborah F Tate, PhD
principal investigator · University of North Carolina, Chapel Hill
Carmina G Valle, PhD
principal investigator · University of North Carolina, Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion